Cerus Corporation (CERS): Price and Financial Metrics

CERS POWR Grades

• Sentiment is the dimension where CERS ranks best; there it ranks ahead of 86.49% of US stocks.
• CERS's strongest trending metric is Value; it's been moving up over the last 178 days.
• CERS ranks lowest in Momentum; there it ranks in the 10th percentile.

CERS Stock Summary

• CERUS CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 79.48% of US listed stocks.
• Over the past twelve months, CERS has reported earnings growth of -40.62%, putting it ahead of 25.85% of US stocks in our set.
• Revenue growth over the past 12 months for CERUS CORP comes in at 30.81%, a number that bests 73.11% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to CERUS CORP are VLD, VNRX, BLI, IPWR, and VRAR.
• CERS's SEC filings can be seen here. And to visit CERUS CORP's official web site, go to www.cerus.com.

CERS Valuation Summary

• In comparison to the median Healthcare stock, CERS's price/sales ratio is 95% higher, now standing at 3.9.
• Over the past 243 months, CERS's price/sales ratio has gone down 40.6.

Below are key valuation metrics over time for CERS.

CERS Growth Metrics

The 3 year cash and equivalents growth rate now stands at 27.26%.
• Its 3 year price growth rate is now at -26.94%.
• Its 3 year net income to common stockholders growth rate is now at 21.24%.

CERS's revenue has moved up $118,896,000 over the prior 52 months.

The table below shows CERS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	187.082	-25.081	-38.274
2022-06-30	182.84	-29.605	-42.229
2022-03-31	172.972	-37.402	-49.201
2021-12-31	159.518	-33.922	-54.374
2021-09-30	143.02	-41.158	-59.636
2021-06-30	130.11	-39.255	-61.338

CERS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CERS has a Quality Grade of C, ranking ahead of 39.02% of graded US stocks.
• CERS's asset turnover comes in at 0.647 -- ranking 61st of 186 Medical Equipment stocks.
• BSGM, NVCR, and STRR are the stocks whose asset turnover ratios are most correlated with CERS.

The table below shows CERS's key quality metrics over time.